Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo

被引:46
|
作者
Lohner, Katrin
Schnaebele, Kerstin
Daniel, Hannelore
Oesterle, Doris
Rechkemmer, Gerhard
Goettlicher, Martin
Wenzel, Uwe
机构
[1] Univ Giessen, Interdisciplinary Res Ctr, D-35392 Giessen, Germany
[2] Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, Freising Weihenstephan, Germany
[3] GSF, Inst Toxicol, Neuherberg, Germany
关键词
C57BL; Caco-2 human intestinal epithelial cells; flavonoids; flow cytometry; P-glycoprotein expression;
D O I
10.1002/mnfr.200600225
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Flavonoids are secondary plant metabolites included in our diet but are also provided in a growing number of supplements. They are suggested to interact with intestinal transport systems including phospbo-glycoprotein (P-gp) which mediates the efflux of a variety of xenobiotics back into the gut lumen. In human intestinal Caco-2 cells, we tested the effects of 14 different flavonoids on P-gp expression in vitro. Protein expression levels were quantified by Western blotting, flow cytometry, and real-time PCR. Except apigenin, all flavonoids at concentrations of 10 mu M increased P-gp expression in Western blotting experiments when cells were exposed to the compounds over 4 wk. Flavone was one of the most effective P-gp inducers in Caco-2 cells and its effects were, therefore, also assessed for changes in P-gp in vivo in the gastrointestinal tract of C57BL/6 mice. P-gp expression was significantly increased by flavone (400 mg/kg body weight x day over 4 wk) in the small intestine but not in the colon which displayed intrinsically the highest expression level. In conclusion, the increase in P-gp expression caused by flavonoids in intestinal epithelial cells in vitro and also in vivo may serve as an adaptation and defense mechanism limiting the entry of lipophilic xenobiotics into the organism.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 50 条
  • [21] Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy
    Szatmari, Peter
    Ducza, Eszter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [22] Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
    Chu, Jessica
    Panfen, Erika
    Wang, Linna
    Marino, Anthony
    Chen, Xue-Qing
    Fancher, R. Marcus
    Landage, Raviraj
    Patil, Omprakash
    Desai, Salil Dileep
    Shah, Devang
    Xue, Yongjun
    Sinz, Michael
    Shen, Hong
    PHARMACEUTICAL RESEARCH, 2023, 40 (11) : 2567 - 2584
  • [23] Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions
    Jessica Chu
    Erika Panfen
    Linna Wang
    Anthony Marino
    Xue-Qing Chen
    R. Marcus Fancher
    Raviraj Landage
    Omprakash Patil
    Salil Dileep Desai
    Devang Shah
    Yongjun Xue
    Michael Sinz
    Hong Shen
    Pharmaceutical Research, 2023, 40 : 2567 - 2584
  • [24] The expression of P-gp, Bcl-2 and VEGF in epithelial ovarian carcinoma and their significance
    Gang, W.
    Luo, F.
    Li, G. L.
    Cheng, J.
    Shi, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability
    Cao, Xianhua
    Yu, Lawrence X.
    Barbaciru, Catalin
    Landowski, Christopher P.
    Shin, Ho-Chul
    Gibbs, Seth
    Miller, Heather A.
    Amidon, Gordon L.
    Sun, Duxin
    MOLECULAR PHARMACEUTICS, 2005, 2 (04) : 329 - 340
  • [26] Dietary regulation of P-gp function and expression
    Zhang, Wenxia
    Han, Yi
    Lim, Siok Lam
    Lim, Lee Yong
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (07) : 789 - 801
  • [27] Expression of P-gP in patients with resistant tuberculosis
    Neves, Ivan
    Costa, Marli
    Carvalho, Simone
    De Castro, Liane
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Neither P-gp SNP variants, P-gp expression nor functional P-gp activity predicts MDR in a preliminary study of plasma cell myeloma
    Drain, Stephen
    Catherwood, Mark A.
    Bjourson, Anthony J.
    Drake, Mary B.
    Kettle, Paul J.
    Alexander, H. Denis
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (04) : 229 - 237
  • [30] Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?
    Ofer, M
    Wolffram, S
    Koggel, A
    Spahn-Langguth, H
    Langguth, P
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 (2-3) : 263 - 271